In ovarian cancer, miR-214 was shown to induce cell survival and cisplatin resistance by targeting the 3′-untranslated region (UTR) of PTEN to suppress its expression and resulting in the activation of the PI3K/Akt signaling pathway [29]. The gene discussed is AKT1; the disease is ovarian carcinoma.